Autologous stem cell transplantation improves microcirculation in systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 68, Issue 1, 2009, Pages 94-98

  Miniati, I ^a,c   Guiducci, S ^a   Conforti, M L ^a   Rogai, V ^a   Fiori, G ^a   Cinelli, M ^a   Saccardi, R ^a   Guidi, S ^a   Bosi, A ^a   Tyndall, A ^b   Matucci Cerinic, M ^a  

^a AOUC   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Department of Biomedicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CAPILLAROSCOPY; CAPILLARY DENSITY; CLINICAL ARTICLE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; MALE; MICROANGIOPATHY; MICROCIRCULATION; NAIL; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; SCLERODERMA, DIFFUSE; STATISTICS, NONPARAMETRIC; TRANSPLANTATION, AUTOLOGOUS; VIDEO RECORDING;

EID: 58349083658     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2007.082495     Document Type: Article

References (23)

1. Kahaleh MB. Vascular involvement in systemic sclerosis. Clin Exp Rheumatol 2004; 22(Suppl 33|:S19-23.
2. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the rale of capillaroscopy. Arthritis Rheum 2003; 48:3023-30.
3. Maricq HR. Widefield capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24:1159-65.
4. Kabasakai Y, Elvins DM, Ring EFJ, McHugh NJ. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 1996; 55:507-12.
5. Maricq HR, Le Roy EC, D'Angelo WA, Medsger TA Jr, Rodnan GP, Sharp GC, et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23:183-9.
6. Andrade LEC, Gabriel A Jr, Assad RL, Ferrari AJL, Atra E. Panoramic nailfold capillaroscopy: a new reading method and normal range. Semin Arthritis Rheum 1990; 20:21-31.
7. Cutolo M, Pizzorni C, Sulli A. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27:155-60.
8. Giacomelli R, Valentini G, Salsano F, Cipriani P, Sambo P, Conforti ML, et al. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis. J Rheumatol 2002; 29:731-6.
9. White B, Moore WC, Wigley FM, Xiao HQ, Wise RA. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132:947-54.
10. Miniati l, Matucci Cerinic M. Pulmonary fibrosis in systemic sclerosis: is treatment with cyclophosphamide more effective than placebo? Nat Clin Pract Rheumatol 2007; 3:372-3.
11. Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54:3962-70.
12. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354:2655-66.
13. Tyndall A, Gratwohl A. The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases. Int J Hematol 2002; 76(Suppl 1):218-22.
14. Tyndall A, Matucci Cerinic M. Haemopoietic stem cell transplantation for the treatment of systemic sclerosis and autoimmune disorders. Expert Opin Biol Ther 2003; 3:1041-9.
15. Sykes M., Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005 2;435:620-7.
16. Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis 2004; 63:974-81.
17. Bombardieri S, Medsger TA Jr. Silman AJ, Valentini G. The assessment of the patient with systemic sclerosis. Introduction. Clin Exp Rheumatol 2003; 21(Suppl 29):S2-4.
18. Nash RA, McSweeney PA, Nelson JL, Wener M, Georges GE, Langston AA, et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. Arthritis Rheum 2006; 54:1982-6.
19. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, et al. Granulocyte colonystimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005; 19:2005-7.
20. Mackiewicz Z, Sukura A, Povilenaité D, Ceponis A, Virtanen L, Hukkanen M, et al. Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin. Clin Exp Rheumatol 2002; 20:641-6.
21. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004; 95:109-16.
22. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, lkeda Y. Defective vasculogenesis in systemic sclerosis Lancet 2004; 364:603-10.
23. Moore TL, Vail A, Herrick AL. Assessment of digital vascular structure and function in response to bosentan in patients with systemic sclerosis-related Raynaud's phenomenon. Rheumatology (Oxford) 2007; 46:363-4.